Self-driving car prototypes need less human help, data show
Self-driving car prototypes appear to be getting better at negotiating California streets and highways without a human backup driver intervening, according to data made public Wednesday by California transportation regulators.
Insurers shrink from exchanges as lawmakers mull changes
The Affordable Care Act's insurance exchanges have become too risky for major health insurers, and that's creating further doubt about coverage options consumers might have next year.
Entrepreneurs: Health law changes may mean finding new jobs
Stay in business for yourself or go back to working for someone else? That's the choice some small business owners and freelancers are worried they may have to make, depending on what changes Congress makes in the health care law.
Big Pharma CEO Says Insurers Will 'Ultimately Determine How Much Patients Pay'
Along with making U.S. job growth a priority, President Trump has also called on the pharmaceutical industry to rein in drug prices. PhRMA CEO Steve Ubl appeared on the FOX Business Network to discuss a meeting that took place between the President and pharmaceutical industry executives early Tuesday.
Phrma CEO: Insurers ultimately decide how much patients pay out of pocket
Phrma CEO Steve Ubl on Trump meeting
Eli Lilly CEO Optimistic Trump Policies Can Boost Pharma Operations, Jobs in U.S.
President Trump met with pharmaceutical industry CEOs Tuesday to discuss a host of topics from drug prices and U.S. manufacturing to the administration’s economic policies. Eli Lilly CEO David A. Ricks discussed the outcome of the meeting.
Eli Lilly CEO: Trump policies could help expand operations in U.S.
Eli Lilly CEO on Trump meeting
Tesla, BMW electrics fall short of highest crash-test rating
Two luxury electric vehicles — the Tesla Model S and the BMW i3 — fell short of getting the highest safety ratings in new crash tests by the insurance industry.
Anthem's Quarterly Revenue Rises 7.6%
Anthem, which is fighting a U.S. government lawsuit to block its deal to buy Cigna, said quarterly revenue rose 7.6 percent.
Japan spokesman: Trump criticism of currency policy off base
Japanese officials have rejected U.S. President Donald Trump's suggestion that Tokyo is seeking to weaken the yen against the U.S. dollar to gain a trade advantage.
Profits jump 25 percent at Germany's Siemens
Siemens AG, the German maker of gas turbines, trains and medical machines, says net income rose 25 percent to 1.93 billion euros ($2.06 billion) for its most recent quarter.
Pfizer misses 4Q profit forecasts
Pfizer Inc. (PFE) on Tuesday reported fourth-quarter net income of $775 million, after reporting a loss in the same period a year earlier.
Aetna beats 4Q profit forecasts
Aetna Inc. (AET) on Tuesday reported fourth-quarter earnings of $139 million.
Pfizer CEO Supports Trump Calls for Lower Pricing, Manufacturing Jobs
Pfizer Inc. (PFE) Chief Executive Ian Read on Tuesday voiced support for President Donald Trump's calls to add drug manufacturing in the U.S., saying a corporate-tax overhaul would pave the way for Pfizer to add U.S. manufacturing jobs.
Trump Pushes Drugmakers for Lower Prices, More U.S. Production
U.S. President Donald Trump on Tuesday called on the pharmaceutical industry to boost U.S. production and lower prices, while also vowing to speed up approval times for new medicines and appoint a new U.S. Food and Drug Administration leader soon.
Lilly 4Q profit surges on diabetes drug sales
Eli Lilly and Co. on Tuesday reported a surge in fourth-quarter profit on a boost in diabetes treatment sales.
Pfizer Quarterly Profit Misses Estimates
Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.
Pfizer 4Q Profit Misses Estimates
Pfizer, which closed its $14 billion acquisition of Medivation in September, reported a lower-than-expected profit, hit by lower demand for products set to go off patent.
Lilly Revenue Rises 7.2% on Demand For New Drugs
Eli Lilly reported a 7.2 percent rise in quarterly revenue, lifted by higher demand for its diabetes drug Trulicity and other new treatments.
Aetna's Quarterly Profit Beats Estimates
Health insurer Aetna, whose $34 billion deal for Humana was blocked last week, reported a higher-than-expected quarterly profit on Tuesday, helped by higher premiums for its plans.













